Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Janssen Research Development Submits Application to U.S. FDA for XARELTO ... - PR Newswire (press release) |
 |
 |
|
PR Newswire (press release) Patients with renal impairment taking P-gp and weak to moderate CYP3A4 inhibitors may have significant increases in exposure, which may increase bleeding risk. Nonvalvular Atrial Fibrillation: For patients with CrCl 15 mL/min to 50 mL/min, |
